While current methods have transformed modern therapeutics, they remain constrained by poor oral bioavailability, stability challenges, cold-chain dependence, and limited patient acceptability associated with injectable administration, according to a review in AAPS PharmSciTech
Wada, M
Lahring J, Leifheit-Nestler M, Ewert A, Herzig N, Koppl C, Pott V, Oh J, Buscher A, Thumfart J, Weber LT, Arbeiter K, Acham-Roschitz B, Tonshoff B, Zivicnjak M, Hohenfellner K, Haffner D (2024) Cystinosis-associated metabolic bone disease across ages and CKD stages 15D/T
J Biol Theory
Same taste, same use in everything (cereal, shakes, coffee, cooking)
The actions of GLP-1 are the target of Ozempic